135 related articles for article (PubMed ID: 38086517)
21. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
[TBL] [Abstract][Full Text] [Related]
22. Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulation.
Elwakil TF; Samy NA; Elbasiouny MS
Lasers Med Sci; 2008 Jul; 23(3):301-6. PubMed ID: 17701270
[TBL] [Abstract][Full Text] [Related]
23. Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.
Grit JL; Johnson BK; Dischinger PS; J Essenburg C; Adams M; Campbell S; Pollard K; Pratilas CA; Triche TJ; Graveel CR; Steensma MR
Epigenetics Chromatin; 2021 Jan; 14(1):7. PubMed ID: 33436083
[TBL] [Abstract][Full Text] [Related]
24. Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with neurofibromatosis type I.
Malhotra N; Levy JMS; Fiorillo L
Pediatr Dermatol; 2019 May; 36(3):360-361. PubMed ID: 30828862
[TBL] [Abstract][Full Text] [Related]
25. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
[TBL] [Abstract][Full Text] [Related]
27. Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
Ly KI; Merker VL; Cai W; Bredella MA; Muzikansky A; Thalheimer RD; Da JL; Orr CC; Herr HP; Morris ME; Chang CY; Harris GJ; Plotkin SR; Jordan JT
Neurology; 2023 Feb; 100(7):e661-e670. PubMed ID: 36332985
[TBL] [Abstract][Full Text] [Related]
28. Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas.
Becker DW
Ann Plast Surg; 1991 Jun; 26(6):582-6. PubMed ID: 1909107
[TBL] [Abstract][Full Text] [Related]
29. Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1.
Balmer JC; Mikhaylov Y; Lewin DN; Mahvi DM; Ramsay Camp E
Am Surg; 2021 Jan; 87(1):128-130. PubMed ID: 32856931
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.
Wozniak B; Bove T; Zawada T; Calik J
Case Rep Dermatol; 2023; 15(1):194-201. PubMed ID: 37899948
[TBL] [Abstract][Full Text] [Related]
31. Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.
Oliveira LB; Geller M; Cunha KS; Santos A; Bernacchi A; Rubenstein AE; Takirambudde S; Mezitis S; de Almeida Ito Brum C; Darrigo LG; Ribeiro MG
Heliyon; 2021 Mar; 7(3):e06518. PubMed ID: 33817379
[TBL] [Abstract][Full Text] [Related]
32. Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.
Wallis D; Stemmer-Rachamimov A; Adsit S; Korf B; Pichard D; Blakeley J; Sarin KY;
Neurology; 2021 Aug; 97(7 Suppl 1):S42-S49. PubMed ID: 34230199
[TBL] [Abstract][Full Text] [Related]
33. Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.
Thalheimer RD; Merker VL; Ly KI; Champlain A; Sawaya J; Askenazi NL; Herr HP; Da JLW; Jordan JT; Muzikansky A; Pearce EM; Sakamoto FH; Blakeley JO; Anderson RR; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S32-S41. PubMed ID: 34230197
[TBL] [Abstract][Full Text] [Related]
34. Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.
Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
[TBL] [Abstract][Full Text] [Related]
35. Prospective, comparative evaluation of three laser systems used individually and in combination for axillary hair removal.
Rao J; Goldman MP
Dermatol Surg; 2005 Dec; 31(12):1671-6; discussion 1677. PubMed ID: 16336886
[TBL] [Abstract][Full Text] [Related]
36. Comparison of efficacy and safety of a novel 755-nm diode laser with conventional 755-nm alexandrite laser in reduction of axillary hairs.
Ayatollahi A; Samadi A; Rajabi-Estarabadi A; Yadangi S; Nouri K; Firooz A
Lasers Med Sci; 2020 Mar; 35(2):373-378. PubMed ID: 31278429
[TBL] [Abstract][Full Text] [Related]
37. Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study.
Tanzi EL; Alster TS
Dermatol Surg; 2004 Feb; 30(2 Pt 1):152-7. PubMed ID: 14756642
[TBL] [Abstract][Full Text] [Related]
38. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
39. CO2 laser treatment of cutaneous neurofibromas.
Roenigk RK; Ratz JL
J Dermatol Surg Oncol; 1987 Feb; 13(2):187-90. PubMed ID: 3100595
[TBL] [Abstract][Full Text] [Related]
40. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]